Literature DB >> 9698042

Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats.

M Isaji1, H Miyata, Y Ajisawa, N Yoshimura.   

Abstract

We studied the effects of tranilast, an anti-allergic and anti-proliferative drug in clinical use, on VEGF/VPF-induced vascular permeability in a rat air pouch model. A large increase in vascular permeability was induced by injection of 4 ml of a 100 ng/ml VEGF/VPF solution into the preformed air pouch. Over a 15-min period, tranilast inhibited the VEGF/VPF-induced vascular permeability in a dose-dependent manner. This result suggests that tranilast, which we recently found to inhibit VEGF/VPF-induced angiogenesis, could also improve VEGF/VPF-dependent increases in vascular permeability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698042     DOI: 10.1016/s0024-3205(98)00277-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.

Authors:  Eman Said; Shehta A Said; Wagdi F Elkashef; Nariman M Gameil; Elsayed M Ammar
Journal:  Inflammopharmacology       Date:  2012-01-26       Impact factor: 4.473

Review 2.  Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Authors:  Slawomir Wojtowicz-Praga
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

3.  Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.

Authors:  S Koyama; H Takagi; A Otani; K Suzuma; K Nishimura; Y Honda
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Avenanthramide supplementation attenuates eccentric exercise-inflicted blood inflammatory markers in women.

Authors:  Ryan T Koenig; Jonathan R Dickman; Choung-Hun Kang; Tianou Zhang; Yi-Fang Chu; Li Li Ji
Journal:  Eur J Appl Physiol       Date:  2015-08-20       Impact factor: 3.078

Review 5.  Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases.

Authors:  Andrea Perrelli; Luca Goitre; Anna Maria Salzano; Andrea Moglia; Andrea Scaloni; Saverio Francesco Retta
Journal:  Oxid Med Cell Longev       Date:  2018-08-23       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.